Literature DB >> 9096667

Lymphocyte and monocyte-induced motility of MCF-7 cells by tumor necrosis factor-alpha.

P M Carpenter1, T Gatanaga, H P Nguyen, J C Hiserodt.   

Abstract

A potentially important tumor-host interaction is increased tumor-cell invasiveness in response to motility factors derived from stromal and lymphoid cells. Conditioned medium of IL-2-stimulated lymphocytes and fractions enriched in either T cells, natural killer (NK) cells, or monocytes induced motility in MCF-7 breast carcinoma cells. ELISA and antibody neutralization studies demonstrated that this effect was due to tumor necrosis factor-alpha (TNF-alpha) secretion by the lymphoid cells or the enriched fractions. Unstimulated leukocytes in direct contact with MCF-7 cells also induced motility that was inhibited by anti-TNF-alpha antiserum. Time-lapse video microscopy of cells exposed to 10 ng/ml TNF-alpha showed that motility was independent of its toxic effects. Immunoperoxidase showed that MCF-7 cells expressed both the 55-kDa and the 75-kDa TNF-alpha receptors (TNFR). Antiserum against the 55-kDa TNFR, like TNF-alpha, induced motility in MCF-7 cells. This was most likely due to cross-linking of the 55-kDa TNFR monomers, since the monomeric F(ab) did not produce this effect. Our results raise the possibility that TNF-alpha-induced motility is one mechanism by which tumor cells overcome the potential anti-tumor immune function of lymphocytes and macrophages in peri-tumoral infiltrates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9096667     DOI: 10.1002/(sici)1097-0215(19970328)71:1<64::aid-ijc12>3.0.co;2-9

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

1.  Antioxidants inhibit TNFalpha-induced motility and invasion of human osteosarcoma cells: possible involvement of NFkappaB activation.

Authors:  K Harimaya; K Tanaka; Y Matsumoto; H Sato; S Matsuda; Y Iwamoto
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFα and Chemokines.

Authors:  Adit Ben-Baruch
Journal:  Cancer Microenviron       Date:  2011-12-22

3.  Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition.

Authors:  Gali Soria; Maya Ofri-Shahak; Ilana Haas; Neora Yaal-Hahoshen; Leonor Leider-Trejo; Tal Leibovich-Rivkin; Polina Weitzenfeld; Tsipi Meshel; Esther Shabtai; Mordechai Gutman; Adit Ben-Baruch
Journal:  BMC Cancer       Date:  2011-04-12       Impact factor: 4.430

4.  Migration of breast cancer cell lines in response to pulmonary laminin 332.

Authors:  Philip M Carpenter; Priyanka Sivadas; Spencer S Hua; Cally Xiao; Alyssa B Gutierrez; Tuan Ngo; Paul D Gershon
Journal:  Cancer Med       Date:  2016-11-22       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.